These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1586715)

  • 61. Changes in filament actin accompanying IgE-dependent and -independent histamine release from IL-3-dependent cultured human basophils.
    Ebisawa M; Saito H; Reason DC; Sakaguchi N; Katsunuma T; Iikura Y
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):71-3. PubMed ID: 1718902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
    Kuna P; Reddigari SR; Schall TJ; Rucinski D; Sadick M; Kaplan AP
    J Immunol; 1993 Mar; 150(5):1932-43. PubMed ID: 7679699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates.
    Mayer P; Valent P; Schmidt G; Liehl E; Bettelheim P
    Blood; 1989 Aug; 74(2):613-21. PubMed ID: 2665851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor.
    Alam R; Forsythe PA; Lett-Brown MA; Grant JA
    Am J Respir Cell Mol Biol; 1992 Oct; 7(4):427-33. PubMed ID: 1382479
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation.
    Ochensberger B; Daepp GC; Rihs S; Dahinden CA
    Blood; 1996 Oct; 88(8):3028-37. PubMed ID: 8874201
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe.
    MacGlashan D; Warner J
    J Leukoc Biol; 1991 Jan; 49(1):29-40. PubMed ID: 1898612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
    Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
    Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity.
    Lopez AF; Eglinton JM; Lyons AB; Tapley PM; To LB; Park LS; Clark SC; Vadas MA
    J Cell Physiol; 1990 Oct; 145(1):69-77. PubMed ID: 1698795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation.
    Mochizuki A; McEuen AR; Buckley MG; Walls AF
    J Allergy Clin Immunol; 2003 Jul; 112(1):102-8. PubMed ID: 12847486
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine priming of human basophils: description of allergen 'nonreleasers'.
    Black KM; Lussier AM; Gion WR; Kasaian MT
    Int Arch Allergy Immunol; 1996 Oct; 111(2):142-51. PubMed ID: 8859222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists.
    Takafuji S; Bischoff SC; De Weck AL; Dahinden CA
    J Immunol; 1991 Dec; 147(11):3855-61. PubMed ID: 1940371
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils.
    Dahinden CA; Kurimoto Y; De Weck AL; Lindley I; Dewald B; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1787-92. PubMed ID: 2478657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of inflammatory mediators released by basophils of asthmatic and control subjects in response to high-affinity IgE receptor aggregation.
    Gilmartin L; Tarleton CA; Schuyler M; Wilson BS; Oliver JM
    Int Arch Allergy Immunol; 2008; 145(3):182-92. PubMed ID: 17912006
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differences in functional consequences and signal transduction induced by IL-3, IL-5, and nerve growth factor in human basophils.
    Miura K; Saini SS; Gauvreau G; MacGlashan DW
    J Immunol; 2001 Aug; 167(4):2282-91. PubMed ID: 11490016
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interleukin 3 activates human blood basophils via high-affinity binding sites.
    Valent P; Besemer J; Muhm M; Majdic O; Lechner K; Bettelheim P
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5542-6. PubMed ID: 2473472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells.
    Matsuda H; Kannan Y; Ushio H; Kiso Y; Kanemoto T; Suzuki H; Kitamura Y
    J Exp Med; 1991 Jul; 174(1):7-14. PubMed ID: 1711569
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Warringa RA; Koenderman L; Kok PT; Kreukniet J; Bruijnzeel PL
    Blood; 1991 Jun; 77(12):2694-700. PubMed ID: 1646045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
    J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.